Another study published in @ATSBlueEditor followed 1611 patients stratified by initial treatment decision (mono, dual, triple therapy) and looked at change in the number of low-risk variables based on initial treatment strategy. 8/8 https://t.co/VcLagz2yKL
RT @cardiomet_CE: 14b) This recommendation is based on non-randomized studies that show marked improvement with triple therapy compared to…
14b) This recommendation is based on non-randomized studies that show marked improvement with triple therapy compared to other regimens (acknowledging the biases that come with such designs) 🔓 https://t.co/4gky55JdPz 🔓 https://t.co/tadcPH03mi https://t.…
RT @Pulmmed_CE: 14b) This recommendation is based on non-randomized studies that show marked improvement with triple therapy compared to ot…